IFNA1 and neoplasm: Oncogenic RAS impairs IFN signaling in tumor cells by decreasing the expression of signal transducer and activator of transcription‐1 (STAT1), STAT2, and interferon regulatory factor‐1 (IRF1),48, 50, 51 signaling molecules important for IFN responsiveness.